Anticonvulsants

CBD Global Issues Third Bi-Weekly Status Report Regarding Management Cease Trade Order

Retrieved on: 
Tuesday, June 15, 2021

As previously announced in the Corporations press releases, the Corporation applied for and was granted a management cease trade order in respect of the delayed Annual Filings (the MCTO) by theAlberta Securities Commission.

Key Points: 
  • As previously announced in the Corporations press releases, the Corporation applied for and was granted a management cease trade order in respect of the delayed Annual Filings (the MCTO) by theAlberta Securities Commission.
  • The MCTO does not affect the ability of the general investing public to trade in the Corporations listed common shares.
  • ABOUT CBD GLOBAL SCIENCES INC.
    CBD Global Sciences Inc., is a vertically integrated hemp-based CBD producer, extractor, and branding investment vehicle which currently owns two product categories, branded under the name AETHICS ( www.aethics.com ) and CANNAOIL ( www.cannaoilshop.com ), which include CBD Oil tinctures (liquid products), CBD capsules, CBD topicals and CBD hydration products.
  • CBD Globals hemp-derived CBD extracts are sold through select distributors, brick and mortar retailers, and online.

Eisai to Divest Rights for Zonegran in Europe and Other Regions to Advanz Pharma

Retrieved on: 
Tuesday, June 15, 2021

Under this agreement, Eisai will divest its rights associated with Zonegran in such European countries, the Middle East, Russia, and Australia to Advanz Pharma.

Key Points: 
  • Under this agreement, Eisai will divest its rights associated with Zonegran in such European countries, the Middle East, Russia, and Australia to Advanz Pharma.
  • Eisai will continue to act as the distributor in Russia, through its local affiliate Limited Liability Company Eisai, and Australia through its local affiliate Eisai Australia Pty.
  • Eisai will retain its rights to Zonegran in Canada, Mexico and Asian countries and continue to distribute the product in certain licensed Asian countries.
  • Eisai believes that this divestiture agreement with Advanz Pharma will lead to maximization of the antiepileptic agent's product value.

Marinus Pharmaceuticals to Present at Multiple Upcoming Investor Conferences

Retrieved on: 
Friday, June 11, 2021

Vice President, Clinical Development

Key Points: 
  • Vice President, Clinical Development
    Speakers: Scott Braunstein, M.D., Chief Executive Officer and Joe Hulihan, M.D., Chief Medical Officer
    All of the above public webcasts may be accessed through the Events & Presentations page of the Investors & Media section of the Marinus website, www.marinuspharma.com .
  • Marinus Pharmaceuticals, Inc. is a pharmaceutical company dedicated to the development of innovative therapeutics to treat seizure disorders.
  • Ganaxolone is a positive allosteric modulator of GABAA receptors that acts on a well-characterized target in the brain known to have anti-seizure, antidepressant and anti-anxiety effects.
  • The company has initiated a Phase 3 trial in refractory status epilepticus.

Advancing Medical R&D for Cannabinoid Medicinal Uses Identifying Growing Number of Health Benefits

Retrieved on: 
Thursday, June 10, 2021

But there's growing awareness about the possible health benefits of CBD oil.

Key Points: 
  • But there's growing awareness about the possible health benefits of CBD oil.
  • An article in Healthline.com published what you need to know about several potential medical uses of CBD and where the research stands.
  • It highlighted Anxiety Relief, Anti-seizure, Neuroprotective, Pain relief and Cancer.CBD may be able to help manage anxiety.
  • You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements.

Innocan Pharma Among Leading CBD Pharma Companies to Participate at Lytham Partners Summer 2021 Investor Conference

Retrieved on: 
Wednesday, June 9, 2021

Iris Bincovich, CEO will participate on the "CBD Treatments" discussion panel on Monday June 14 at 11:00AM ET.

Key Points: 
  • Herzliya, Israel and Calgary, Alberta--(Newsfile Corp. - June 9, 2021) - Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) (the "Company" or "Innocan"), is pleased to announce that it will participate at the Lytham Partners Summer 2021 Investor Conference on June 14 through June 16, 2021.
  • Management will also be participating in virtual one-on-one meetings throughout the event, which run from June 14 through June 16, 2021.
  • The Company, through its wholly owned Israeli subsidiary, Innocan Pharma Ltd. ("Innocan Israel"), is a pharmaceutical tech company that focuses on the development of several drug delivery platforms combining cannabidiol ("CBD").
  • The founders and officers of Innocan have commercially successful track records in the pharmaceutical and technology sectors in Israel and globally.

Chairman of New You, Inc. CBD Acquisition Subsidiary ST Brands to Speak on Panel Entitled "The Companies Driving International Market Growth" at the Benzinga Cannabis Capital Conference, Thursday, June 3

Retrieved on: 
Wednesday, June 2, 2021

New You, Inc. (OTCQB: NWYU) wholly-owned subsidiary ST Brands Corp is a capital and growth platform for high potential consumer cannabidiol (CBD) companies that create, develop, market, and sell unique and proprietary products to various segments of the global consumer market.

Key Points: 
  • New You, Inc. (OTCQB: NWYU) wholly-owned subsidiary ST Brands Corp is a capital and growth platform for high potential consumer cannabidiol (CBD) companies that create, develop, market, and sell unique and proprietary products to various segments of the global consumer market.
  • ST Brands applies financial, operational, branding resource infrastructure to deliver turnkey business services and achieve economies of scale in capital, sourcing, production, packaging, and sales.
  • ST Brands acquires scalable cannabis companies with the potential to become sector leaders in the legal cannabis market.
  • The conference will feature an interactive forum of live presentations from top CEOs, investors, and leaders in the cannabis space.

Charlotte's Web and University of Colorado-Boulder Collaborating on Sleep and Anxiety Studies

Retrieved on: 
Wednesday, June 2, 2021

The Company is the only hemp CBD brand supporting the University of Colorado REACH Center's milestone study.

Key Points: 
  • The Company is the only hemp CBD brand supporting the University of Colorado REACH Center's milestone study.
  • There is some anecdotal evidence on the ability of CBN to help with sleep but little substantiated clinical or preclinical evidence to validate these pervasive claims.
  • "We're honored to team up with CU's REACH Center to explore the potential impacts of full-spectrum hemp extract with CBD and CBN on anxiety and sleep quality."
  • The Charlotte's Web family of brands includes Charlotte's Web, CBD Medic, CBD Clinic, and Harmony Hemp.

CBD Global Issues Second Bi-Weekly Status Report Regarding Management Cease Trade Order

Retrieved on: 
Friday, May 28, 2021

As previously announced in the Corporations press releases, the Corporation applied for and was granted a management cease trade order in respect of the delayed Annual Filings (the MCTO) by theAlberta Securities Commission.

Key Points: 
  • As previously announced in the Corporations press releases, the Corporation applied for and was granted a management cease trade order in respect of the delayed Annual Filings (the MCTO) by theAlberta Securities Commission.
  • The MCTO does not affect the ability of the general investing public to trade in the Corporations listed common shares.
  • ABOUT CBD GLOBAL SCIENCES INC.
    CBD Global Sciences Inc., is a vertically integrated hemp-based CBD producer, extractor, and branding investment vehicle which currently owns two product categories, branded under the name AETHICS ( www.aethics.com ) and CANNAOIL ( www.cannaoilshop.com ), which include CBD Oil tinctures (liquid products), CBD capsules, CBD topicals and CBD hydration products.
  • CBD Globals hemp-derived CBD extracts are sold through select distributors, brick and mortar retailers, and online.

Summer Means a Return to Activity, and Time for Cibadol Products

Retrieved on: 
Wednesday, May 26, 2021

A recent study reported that a growing number of consumers started using cannabidiol (CBD) products during the COVID-19 pandemic.

Key Points: 
  • A recent study reported that a growing number of consumers started using cannabidiol (CBD) products during the COVID-19 pandemic.
  • This summer is also a good time for consumers to become acquainted or reacquainted -- with Cibadol (CY-buh-dol), one of the most potent, cost-efficient and highest-quality brands of CBD products available.
  • "We've been growing, harvesting, processing our own top-of-the-line hemp, and manufacturing our CBD products since 2015," said Andy Rodosevich, CEO of Hemp Depot, the parent company of Cibadol.
  • The Cibadol line of products is available online in all 50 states.

VETCBD Announces Partnership With Best Friends Animal Society, Bringing CBD to Thousands of Shelter Pets in Need

Retrieved on: 
Tuesday, May 25, 2021

Veterinarian-founded cannabis company VETCBD today announced an 18-month partnership with Best Friends Animal Society to support animals and help the national animal welfare organization achieve its goal of ending the killing of shelter pets by 2025.

Key Points: 
  • Veterinarian-founded cannabis company VETCBD today announced an 18-month partnership with Best Friends Animal Society to support animals and help the national animal welfare organization achieve its goal of ending the killing of shelter pets by 2025.
  • As the nonprofits CBD partner, VETCBD will provide their hemp-derived CBD oil to Best Friends and its Network Partners, aiding thousands of animals in the process.
  • VETCBD has always worked to help as many animals as we possibly can, said Dr. Tim Shu, founder and CEO of VETCBD.
  • Through our partnership with VETCBD, many shelter pets across the country will benefit from the calming effects of its products, said Candi Maciel, director of corporate partnerships at Best Friends Animal Society.